• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


Medical Technologies Firm to Create 100+ Jobs at New Wisconsin Facility

Wisconsin-based SHINE Medical Technologies has announced plans to establish its molybdenum-99 production facility in Janesville, WI, and hire at least 100 full-time employees once the plant is operational.

SHINE serves the medical tracer industry sector by providing medical ingredients used to detect/treat heart disease and cancer in nearly 100,000 patients each day.

"As a company that grew in partnership with research conducted at UW-Madison and the Morgridge Institute for Research, one of our primary goals was to grow this business in Wisconsin and leverage its talented workforce," said SHINE's Founder/CEO Greg Piefer, Ph.D.

The company's proposed facility, to be located in the STH 11 Business Park, will have the capacity to produce enough moly-99 to supply about half of the U.S. nuclear medical isotope needs. (Moly-99 is a medical isotope to help detect heart disease and determe stages of cancer progression.) Historically, the majority of the moly-99 used in the U.S. has been produced in Canada or from other locations across the globe.

Pending formal approval, SHINE's project will be supported by a combination of resources, including a Janesville Tax Increment Financing (TIF) package and assistance from the Wisconsin Economic Development Corporation. The facility marks the second medical technologies announcement in Rock County within the last eight months.


Exclusive Research